Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis

Background . To better inform clinicians on the optimal management of patients on oral anticoagulation who need to undergo surgery or invasive procedures, the authors performed a decision analysis examining whether a perioperative aggressive or minimalist strategy results in greater quality-adjusted survival. Methods . A decision analysis model was created comparing withholding warfarin (minimalist strategy) to withholding warfarin and administering treatment-dose subcutaneous low-molecular-weight heparin (LMWH) or intravenous heparin perioperatively (aggressive strategy). The base-case analysis examined a hypothetical 60-year-old hypertensive individual with mechanical aortic valve replacement undergoing major abdominal surgery. A probabilistic sensitivity analysis was performed using a Monte Carlo simulation with quality-adjusted life expectancy (QALE) as the outcome. Secondary analyses examined patients with a mechanical mitral valve and atrial fibrillation. Sensitivity analyses were performed for each variable. Results . Under the base-case scenario, the minimalist strategy was preferred for 78% of trials in the Monte Carlo simulation, with a mean benefit of 0.003 years (95% confidence interval, -0.005 years to 0.011 years). Sensitivity analyses based on point estimates indicate that the aggressive strategy is preferred when the annual stroke rate is >5.6% or the increase in postoperative major bleeding induced by heparin is <2.0%; however, the benefit is small over the range of plausible values. Conclusions . For most patients with a mechanical aortic valve or atrial fibrillation undergoing major surgery, a minimalist strategy of simply withholding oral anticoagulation provides similar QALE as an aggressive strategy of administering perioperative subcutaneous LMWH or intravenous heparin. The aggressive therapy provides greater QALE for patients at higher risk of stroke (e.g., mechanical mitral valves), although the benefit is small.

[1]  J. Douketis,et al.  Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin , 2004, Circulation.

[2]  J. Douketis,et al.  Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. , 2004, Archives of internal medicine.

[3]  D. Blacker,et al.  Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy , 2003, Neurology.

[4]  A. Turpie,et al.  Perioperative management of patients receiving oral anticoagulants: a systematic review. , 2003, Archives of internal medicine.

[5]  Martha J. Radford,et al.  Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .

[6]  L. Kalra,et al.  Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice? , 2001, Archives of internal medicine.

[7]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[8]  T O Tengs,et al.  Health-related quality of life after stroke a comprehensive review. , 2001, Stroke.

[9]  R. McLeod,et al.  Subcutaneous Heparin Versus Low-Molecular-Weight Heparin as Thromboprophylaxis in Patients Undergoing Colorectal Surgery: Results of the Canadian Colorectal DVT Prophylaxis Trial: A Randomized, Double-Blind Trial , 2001, Annals of surgery.

[10]  S. Port Systolic blood pressure and mortality , 2000, The Lancet.

[11]  C. Francis,et al.  Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients : A double-blind, randomized comparison , 2000 .

[12]  B. Gage,et al.  Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants. , 2000 .

[13]  B. Morrey,et al.  Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement , 2000, Annals of Internal Medicine.

[14]  F. Morady,et al.  A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. , 2000, Journal of the American College of Cardiology.

[15]  W M O'Fallon,et al.  Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. , 2000, Stroke.

[16]  S. Clark,et al.  Effect of low molecular weight heparin (fragmin) on bleeding after cardiac surgery. , 2000, The Annals of thoracic surgery.

[17]  S. Takagi,et al.  Relationship between blood pressure level and mortality rate: an 18‐year study conducted in two rural communities in Japan , 2000, Journal of hypertension.

[18]  R. Hiebert,et al.  Anticoagulant Treatment of Thromboembolism with Intravenous Heparin Therapy in the Early Postoperative Period Following Total Joint Arthroplasty* , 2000, The Journal of bone and joint surgery. American volume.

[19]  J. Douketis,et al.  Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. , 1999, Chest.

[20]  O. Benavente,et al.  Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 1999, Annals of Internal Medicine.

[21]  G. Raskob,et al.  Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. , 1999, Archives of internal medicine.

[22]  K. Carter,et al.  Phacoemulsification and lens implantation in patients treated with aspirin or warfarin , 1998, Journal of cataract and refractive surgery.

[23]  H. Spotnitz,et al.  Outpatient Pacemaker Procedures in Orally Anticoagulated Patients , 1998, Pacing and clinical electrophysiology : PACE.

[24]  M. Wahl Dental surgery in anticoagulated patients. , 1998, Archives of internal medicine.

[25]  David M. Smith,et al.  Risk of major hemorrhage for outpatients treated with warfarin , 1998, Journal of General Internal Medicine.

[26]  J. Hirsh,et al.  Management of anticoagulation before and after elective surgery. , 1997, The New England journal of medicine.

[27]  B. Gage,et al.  The Effect of Stroke and Stroke Prophylaxis With Aspirin or Warfarin on Quality of Life , 1996 .

[28]  Vittorio Pengo,et al.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.

[29]  M. McDonell,et al.  Management and Prognosis of Life-threatening Bleeding During Warfarin Therapy , 1996 .

[30]  S. Fihn,et al.  The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin , 1996, Annals of Internal Medicine.

[31]  C. Legnani,et al.  Warfarin Withdrawal , 1996, Clinical pharmacokinetics.

[32]  Gordon B. Hazen,et al.  A Cost-effectiveness Analysis of Total Hip Arthroplasty for Osteoarthritis of the Hip , 1996 .

[33]  C. Otley,et al.  Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs. , 1996, Archives of dermatology.

[34]  A. Haeberli,et al.  Rebound after cessation of oral anticoagulant therapy: the biochemical evidence , 1996, British journal of haematology.

[35]  B. Gersh,et al.  Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota. , 1995, Mayo Clinic proceedings.

[36]  J. Vandenbroucke,et al.  Optimal oral anticoagulant therapy in patients with mechanical heart valves. , 1995, The New England journal of medicine.

[37]  A S Detsky,et al.  Users' guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? Evidence Based Medicine Working Group. , 1995, JAMA.

[38]  C. Colwell,et al.  Prevention of venous thromboembolism. , 1994, Chest.

[39]  Stroke Investigators Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study , 1994, The Lancet.

[40]  F. R. Rosendaal,et al.  Thromboembolic and Bleeding Complications in Patients With Mechanical Heart Valve Prostheses , 1994, Circulation.

[41]  R. Beyth,et al.  Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. , 1993, The American journal of medicine.

[42]  W G Henderson,et al.  A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. , 1993, The New England journal of medicine.

[43]  V. Kakkar,et al.  Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery , 1993, The Lancet.

[44]  J. Clausen,et al.  Blood pressure and mortality: an epidemiological survey with 10 years follow-up. , 1992, Journal of human hypertension.

[45]  M. Blombäck,et al.  Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients. , 1991, European heart journal.

[46]  C. Roberts,et al.  Cataract surgery in anticoagulated patients , 1991, Journal of cataract and refractive surgery.

[47]  F. Crawford,et al.  Long-term results of aortic valve replacement. , 1991, Cardiology clinics.

[48]  S. Goldhaber,et al.  Complications of heparin therapy after total joint arthroplasty. , 1990, The Journal of bone and joint surgery. American volume.

[49]  G. A. Robinson,et al.  Warfarin and cataract extraction. , 1989, The British journal of ophthalmology.

[50]  D. Ilstrup,et al.  Ocular surgery on patients receiving long-term warfarin therapy. , 1989, American journal of ophthalmology.

[51]  L Goldman,et al.  Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. , 1989, The American journal of medicine.

[52]  L. McMahan,et al.  Anticoagulants and cataract surgery , 1988, Journal of cataract and refractive surgery.

[53]  P. T. Onundarson,et al.  Chronic atrial fibrillation--epidemiologic features and 14 year follow-up: a case control study. , 1987, European heart journal.

[54]  J. Hirsh,et al.  A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. , 1986, The New England journal of medicine.

[55]  C. Mok,et al.  Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. , 1985, Circulation.

[56]  J R Beck,et al.  A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. , 1982, The American journal of medicine.

[57]  G. Lawrie,et al.  Clinical experience with the Smeloff-Cutter prosthesis: 1- to 12-year follow-up. , 1980, The Annals of thoracic surgery.

[58]  E. Lefrak,et al.  Aortic Valve Replacement: A Ten‐Year Follow‐up of Non‐Cloth‐Covered vs Cloth‐Covered Caged‐Ball Prosthesesm , 1977, Circulation.

[59]  J. Criley,et al.  Presystolic murmur in atrial fibrillation. , 1977, Circulation.

[60]  W. Stanford,et al.  Thromboembolic phenomena in patients with prosthetic aortic valves who did not receive anticoagulants. , 1977, The Annals of thoracic surgery.

[61]  L. Poller,et al.  EVIDENCE FOR "REBOUND" HYPERCOAGULABILITY AFTER STOPPING ANTICOAGULANTS. , 1964, Lancet.

[62]  M. Prins,et al.  Fixed dose subcutaneous low molecular weight heparins versus adjusted dose infractionated heparin for venous thromboembolism [Cochrane review] , 2004 .

[63]  J. Hirsh,et al.  Managing oral anticoagulant therapy. , 2001, Chest.

[64]  M. Cucherat,et al.  Prevention of Venous Thromboembolism in Internal Medicine with Unfractionated or Low-molecular-weight Heparins: A Meta-analysis of Randomised Clinical Trials , 2000, Thrombosis and Haemostasis.

[65]  M. Glanz,et al.  The Sharer , 2000, Annals of Internal Medicine.

[66]  D. Zahger Use of Enoxaparin for the Chronically Anticoagulated Patient Before and After Procedures , 1999 .

[67]  R. N. Anderson,et al.  National Vital Statistics Reports , 1999 .

[68]  M. Gould,et al.  Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. , 1999, Annals of internal medicine.

[69]  J. Pawlak,et al.  Prospective double-arm study of fibrinolysis in surgical patients. , 1998, The Journal of surgical research.

[70]  F. Giubilei,et al.  Long-term prognosis after a minor stroke: 10-year mortality and major stroke recurrence rates in a hospital-based cohort. , 1998, Stroke.

[71]  J. Paramo,et al.  Hemostatic markers in surgery: a different fibrinolyfic activity may be of pathophysiological significance in orthopedic versus abdominal surgery , 1997, International journal of clinical & laboratory research.

[72]  A. Laupacis,et al.  Prognosis of individuals with atrial fibrillation. , 1996, The Canadian journal of cardiology.

[73]  J. Madura,et al.  The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures. , 1994, The American surgeon.

[74]  H. White,et al.  Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation : stroke prevention in atrial fibrillation II study. Commentary , 1994 .

[75]  J. Vandenbroucke,et al.  Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. , 1993, Archives of internal medicine.

[76]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[77]  Jerome P. Kassirer,et al.  A Convenient Approximation of Life Expectancy , 1992 .

[78]  R. Collins,et al.  Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin: Overview of Results of Randomized Trials in General, Orthopedic, and Urologic Surgery , 1989 .

[79]  R. Ling Anticoagulants and cataract surgery. , 1988, Ophthalmic surgery.

[80]  R. Bloch,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.